Moderna today asked the Food and Drug Administration to grant full approval of its COVID-19 vaccine for people age 18 years and older. So far, 124 million doses of the Moderna vaccine have been administered in the U.S. Moderna’s request for a priority review of its Biologics License Application includes data submitted on a rolling basis culled from its ongoing phase 3 clinical trial. Moderna is currently tracking about three weeks behind Pfizer, whose application for full FDA approval of its own COVID-19 vaccine was submitted May 7.

Related News Articles

Headline
The Centers for Disease Control and Prevention last night endorsed Moderna’s COVID-19 vaccine for children aged 6-17, as its advisory committee…
Headline
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today unanimously recommended Moderna’s COVID-19 vaccine for…
Blog
A recent article in the Washington Post “COVID bailout rescued some hospitals while enriching others” is wrong. The reality is that all of America’s hospitals…
Headline
More than 1 million prescriptions for the COVID-19 antiviral pills Lagevrio and Paxlovid were dispensed between late December 2021 and May 2022, but dispensing…
Headline
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices on Saturday recommended the Moderna vaccine for children aged 6…
Headline
The Food and Drug Administration today authorized Moderna’s COVID-19 vaccine for children aged 6 months through 17 years old and Pfizer’s COVID-19 vaccine for…